Staley Brod is a Neurology physician affiliated with Medical College of Wisconsin. OpenAlex indexes 97 publications with 1,863 citations (h-index 25); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9200 W Wisconsin Ave
Department Of Neurology
Milwaukee, WI 532263522
Telephone
414-805-5200Registry record last updated 21 Apr 2016.
Clinical trials
- Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations
Sponsor: The University of Texas Health Science Center, Houston
- AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS
Sponsor: The University of Texas Health Science Center, Houston
- Interferon-Alpha for Diabetes Mellitus Type 1
Sponsor: The University of Texas Health Science Center, Houston
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ANI Pharmaceuticals, Inc.Program year202526 payments$32,801openpaymentsdata.cms.gov ↗
- EMD Serono, Inc.Program year202521 payments$25,250openpaymentsdata.cms.gov ↗
- Boston Scientific CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Anti-Inflammatory Agents: An Approach to Prevent Cognitive Decline in Alzheimer’s Disease
Journal of Alzheimer s Disease
2021 - Review of approved NMO therapies based on mechanism of action, efficacy and long-term effects
Multiple Sclerosis and Related Disorders
2020 - Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments
Multiple Sclerosis Journal - Experimental Translational and Clinical
2019 - Ingested ACTH blocks Th17 production by inhibiting GALT IL-6
Journal of the Neurological Sciences
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Razelle Kurzrock, MD
Medical College of Wisconsin
Mary Horowitz, MD
Medical College of Wisconsin
Janet Rader, MD
Medical College of Wisconsin
Bruce Camitta, MD
Medical College of Wisconsin
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”